Vaccine Research Area, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, FISABIO, Valencia, Spain.
Facultad de Medicina y Ciencias de la Salud, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain.
Health Expect. 2023 Feb;26(1):429-439. doi: 10.1111/hex.13675. Epub 2022 Nov 23.
The informed consent process is key to safeguarding the autonomy of the participant in medical research. For this process to be valid, the information presented to the potential participant should meet their needs and be understood by them. The i-CONSENT project has developed 'Guidelines for adapting the informed consent process in clinical trials' which aim to improve informed consent so that they are easier to understand and better adapted to the needs and preferences of the target population. The best way to tailor information to the characteristics and preferences of the target population is to involve the community itself.
Following guidelines developed by i-CONSENT, assent materials were co-created for a mock clinical trial of the human papillomavirus vaccine in adolescents. During the process, two design thinking sessions were conducted involving a total of 10 children and 5 parents. The objectives of the sessions were to find out the children's opinion of the informed consent (assent in their case) process in clinical trials, identify the parts that were most difficult to understand and alternatives for their presentation and wording, identify the preferred formats for receiving the information and the main characteristics of these formats, design a video explaining the clinical trial and evaluate a tool for assessing comprehension.
Assent materials were co-created in three formats: a web-based material following a layered approach; a video in story format; a pdf document with an innovative way of presenting information compared to traditional assent documents. In addition, the Comprehension of Assent Questionnaire was co-designed, based on the Quality of Informed Consent questionnaire.
The design thinking methodology has proven to be an easy and useful tool for involving children in designing information tailored to their needs and preferences.
A sample of the target population participated in the design and piloting of the materials created using design thinking methodology. In addition, patient representatives participated in the design and evaluation of the guidelines developed by the i-CONSENT project that were followed for the development of the materials in this study.
知情同意过程是保护医学研究参与者自主权的关键。为了使该过程有效,向潜在参与者提供的信息应满足他们的需求并被他们理解。i-CONSENT 项目制定了“临床试验中知情同意过程改编指南”,旨在改善知情同意,使其更易于理解,并更好地适应目标人群的需求和偏好。使信息与目标人群的特征和偏好相匹配的最佳方法是让社区本身参与进来。
根据 i-CONSENT 制定的指南,共同创作了青少年人乳头瘤病毒疫苗模拟临床试验的同意材料。在这个过程中,进行了两次设计思维会议,总共涉及 10 名儿童和 5 名家长。会议的目的是了解孩子们对临床试验中知情同意(在他们的情况下是同意)过程的看法,确定最难以理解的部分以及替代呈现和措辞的方法,确定接收信息的首选格式及其主要特征,并设计一个解释临床试验的视频以及评估理解评估工具。
同意材料以三种格式共同创作:采用分层方法的基于网络的材料;以故事格式呈现的视频;与传统同意文件相比具有创新呈现信息方式的 PDF 文件。此外,还共同设计了基于知情同意质量问卷的同意理解问卷。
设计思维方法已被证明是一种简单而有用的工具,可用于让儿童参与设计符合其需求和偏好的信息。
目标人群的样本参与了使用设计思维方法设计和试用材料。此外,患者代表参与了 i-CONSENT 项目制定的指南的设计和评估,这些指南是为了开发本研究中使用的材料而遵循的。